Hold Castrol India, says Rajesh Agarwal

Rajesh Agarwal of AUM Capital told CNBC-TV18, "Castrol India is one stock that one can hold for four to five years down the line because one, the management is very good. The company has been doing well from years and the automotive lubricant business of this company is doing well. The most important part is subdued crude price is a big positive for the company and thus company commands pricing premium due to better product mix and their brand."

"I would say hold on to the stock. For the medium-term, we have a target of around Rs 460 levels. I would say make an SIP kind of thing and keep on adding stocks on every dips," he added.

"The management of Aurobindo Pharma was very confident speaking that they are going to face only single digit price pressure, against double digit price by other peers. The fact remains that the company has a very strong product portfolio and with recent acquisition in US and EU, I think this company has got a better position among large formulations players. Pharmaceutical companies at this point of time are facing bad weather not only from US Authorities but also on revenue front, both on domestic and international market."

"However, the fact remains that pharmaceutical as a sector cannot be out of favour for very long time and if somebody is ready to hold for three to four quarters, one can expect decent returns. I would say if one has funds with him, one can even add Aurobindo at these levels because valuations are quite cheap. Trading at a P/E of less than 15 I think it can give decent returns," he said.

"As far as Nectar Life Science is concerned, I think fundamentals are not justifying the kind of valuations it is taking at this point of time. Even after the cut, I would say get out of that stock, switch this money to Aurobindo."